CV Sciences (CVSI) Other Non Operating Income (2014 - 2026)
CV Sciences (CVSI) posted Other Non Operating Income of $20000.0 for Q1 2026, down 94.94% sequentially from $395000.0 in Q4 2025, and down 47.37% YoY from $38000.0 in Q1 2025.
CV Sciences (CVSI) Other Non Operating Income (2014 - 2026) Analysis & Trends
CV Sciences has reported Other Non Operating Income for 11 years, with the latest figure at $20000.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 47.37% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $415000.0 (up 638.96% YoY) and the FY2025 annual result came in at $7000.0, changed N/A from the prior year.
- Other Non Operating Income declined to $20000.0 in Q1 2026 per CVSI's latest filing, from $395000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.3 million in Q4 2022 and troughed at -$336000.0 in Q2 2022.
- A 5-year average of $123250.0 and a median of -$6000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income slumped 1050.0% in 2024, then jumped 2000.0% in 2025.
- Over 5 years, Other Non Operating Income stood at $1.3 million in 2022, then tumbled by 47.55% to $695000.0 in 2023, then sank by 116.55% to -$115000.0 in 2024, then surged by 443.48% to $395000.0 in 2025, then plunged by 94.94% to $20000.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $20000.0, $395000.0, and $38000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | CV Sciences | 4.12 Mn | 3.86 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 469,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Sep 30, 2024 | -115,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 695,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -209,000.00 |
| Mar 31, 2023 | -56,000.00 |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | -266,000.00 |
| Jun 30, 2022 | -336,000.00 |
| Sep 30, 2021 | 2.95 Mn |
| Dec 31, 2018 | -2,614.00 |
| Dec 31, 2017 | -767,875.00 |
| Sep 30, 2017 | 10,987.00 |
| Jun 30, 2017 | -132,514.00 |
| Mar 31, 2017 | 210,600.00 |
| Dec 31, 2016 | -1.07 Mn |